leukemia
Treating Colon Cancer With Leukemia Drug
A study in mice suggests that the leukemia drug Imatinib could also be used to treat and prevent colon cancer.
The Journey From Stem Cell To Blood Cell Revealed
Scientists have created a comprehensive catalog of the changes in RNA as stem cells commit to different blood cell lineages.
Teaching Old Drugs New Tricks
Understanding why RUNX deficiencies result in leukemia has led to new applications for PARP inhibitors.
Scientists Discover The Genetic Basis Of Common Childhood Leukemia
Mutually exclusive mutations in the genes RAS and JAK2 account for two-thirds of all acute lymphoblastic leukemia in children.
3SBio Licenses DiNonA’s Anti-Leukemia Treatment
3SBio and DiNonA will develop Leukotuximab, an anti JL-1 antibody indicated for the treatment of acute leukemia.
Lipids: The New Target For Cancer Immunotherapy
Lipids, rather than proteins, expressed by leukemia cells are a promising new target for T cell-driven cancer immunotherapy.
Blocking STAT5 To Fight Leukemia
Blocking STAT5 in conjunction with standard tyrosine kinase inhibitor drugs could be a powerful one-two punch that kills leukemic cells.
Otsuka Acquires Leukemia Drug Dacogen® From Eisai
Otsuka Pharmaceutical acquires two drugs, Dacogen® and E7727, from Eisai Co. to enhance their leukemia drug portfolio.
Twins Provide Clues For Fighting Cancer
Researchers who analyzed the genomes of a pair of twins have identified a novel drug target for treating recurring and deadly malignancies.
